Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea.
Deparment of Family Medicine, Yangsan Pusan National University Hospital, Yangsan, Korea.
J Korean Med Sci. 2014 Jan;29(1):32-7. doi: 10.3346/jkms.2014.29.1.32. Epub 2013 Dec 26.
The epidemiology on human papillomavirus (HPV) among human immunodeficiency virus (HIV)-infected women in Korea is not well established. A retrospective study was conducted to determine the prevalence and genotype distribution of HPV infection among HIV-infected women in Korea. HPV DNA genotype and cervical cytology were examined in 60 HIV-positive women and 1,938 HIV-negative women. HPV genotypes were analyzed by using a HPV DNA chip. HIV-infected women had higher prevalence of high-risk HPV (hr-HPV) infection (30% vs 4.9%, adjusted odds ratio [AOR], 6.96; 95% confidence interval [CI], 3.63-13.34, P<0.001) and abnormal cervical cytology (18.3% vs 1.8%, AOR, 10.94; 95% CI, 5.18-23.1, P<0.001) compared with controls. The most common hr-HPV genotype detected in HIV-infected women was HPV 16 (10%), followed by 18 (6.7%) and 52 (5%). Prevalence of quadrivalent vaccine-preventable types (HPV 6, 11, 16, and 18) was 21.7% and 2.3% in HIV-positive women and HIV-negative women, respectively. Age was a significant risk factor for hr-HPV infection in HIV-infected women (P=0.039). The presence of hr-HPV was significantly associated with abnormal cervical cytology (P<0.001). These findings suggest that HPV testing for cervical cancer screening in HIV-infected women would be necessary, particularly among young age group.
韩国人类免疫缺陷病毒(HIV)感染女性的人乳头瘤病毒(HPV)流行病学情况尚不清楚。本研究回顾性分析了韩国 HIV 感染女性 HPV 感染的流行率和基因型分布。对 60 例 HIV 阳性女性和 1938 例 HIV 阴性女性进行了 HPV DNA 基因型和宫颈细胞学检查。采用 HPV DNA 芯片分析 HPV 基因型。与对照组相比,HIV 感染女性高危型 HPV(hr-HPV)感染(30% vs 4.9%,调整优势比[OR],6.96;95%置信区间[CI],3.63-13.34,P<0.001)和异常宫颈细胞学(18.3% vs 1.8%,OR,10.94;95%CI,5.18-23.1,P<0.001)的流行率更高。在 HIV 感染女性中最常见的 hr-HPV 基因型是 HPV 16(10%),其次是 HPV 18(6.7%)和 HPV 52(5%)。四价疫苗可预防型(HPV 6、11、16 和 18)在 HIV 阳性和 HIV 阴性女性中的流行率分别为 21.7%和 2.3%。年龄是 HIV 感染女性发生 hr-HPV 感染的显著危险因素(P=0.039)。hr-HPV 的存在与异常宫颈细胞学显著相关(P<0.001)。这些发现表明,对 HIV 感染女性进行宫颈癌筛查时需要进行 HPV 检测,尤其是在年轻女性中。